News
In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...
Novo Nordisk ( NVO 1.82%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for ...
That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results